News
- Kindred Biosciences Announces Third Quarter 2018 Financial ResultsNovember 7, 2018 - 4:01 p.m.
- Kindred Biosciences Announces Positive Results from Pilot Effectiveness Study of its Fully Caninized IL-31 Antibody for the Treatment of Atopic Dermatitis in Dogs and Issuance of U.S. PatentOctober 30, 2018 - 4:02 p.m.
- Kindred Biosciences to Announce Third Quarter 2018 Financial ResultsOctober 24, 2018 - 8:31 a.m.
Kindred Biosciences' Second Quarter 2018 Financial Results
Webcast Presentation